Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 4Leukemia 4Hodgkin Disease 4Burkitt Lymphoma 4Lymphoma, B-Cell 3Hematologic Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Philadelphia Chromosome 1Neoplasms 1Multiple Myeloma 1Mastocytosis, Systemic 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Myeloid, Acute 1Leukemia, Mast-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Leukemia, B-Cell 1Graft vs Host Disease 1Blastic Plasmacytoid Dendritic Cell Neoplasm 1

Interventions

Cyclophosphamide 43Tacrolimus 39Methotrexate 30Cyclosporine 28Mycophenolic Acid 25fludarabine phosphate 22Antilymphocyte Serum 22Melphalan 20Busulfan 20Sirolimus 18Methylprednisolone 18Radiotherapy 17Peripheral Blood Stem Cell Transplantation 17fludarabine 15Whole-Body Irradiation 15Filgrastim 14Thiotepa 8Rituximab 8thymoglobulin 7Etoposide 7Granulocyte Colony-Stimulating Factor 6Cord Blood Stem Cell Transplantation 6Transplantation 5Therapeutics 5Stem Cell Transplantation 5Prednisone 5Flow Cytometry 5Cyclosporins 5Alemtuzumab 5ruxolitinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Diphenhydramine × Lymphoid × Clear all
NCT00185692 2019-12-04

Allogeneic Transplantation From Related Haploidentical Donors

Stanford University

Phase 2 Completed
16 enrolled 8 charts
LymphoidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Leukemia, Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡